Marcelo Weber - CEO and Founder
Focus on
- Leadership, Strategy , business modeling, product launching, branding, marketing and sales strategy.
- Large experience in pharmaceutical market such as retail , biotech, niche and super niche products.
Background
- More than 22 years of experience acting as a Business Director in Pharmaceutical Companies such as Boehringer Ingelheim, Serono Biotech and Merck.
- Social Communication with emphases in Advertisement by FAAP - Fundação Armando Alvares Penteado.
- Executive MBA from Universidade de São Paulo - FIA/USP focused on Business Strategy.
- IMP Member - International Management Program - An International leadership development program with participants from more than 20 countries including Latin America, Europe, North America, China, India, Korea etc.
Relevant project
- Business Unit Director of Specialty Pharma, managing an exclusive mix of Biotech products in Multiple Scleroses, Fertility, PKU and Growth Hormone.
- Member of international task force to evaluate biosimilars / follow on products market potential / sales impact over original products in segments like multiple scleroses, rheumatoid arthritis, psoriasis, oncology etc.
- A Team Leader responsible to deal directly with Brazilian Health Authorities processes like: HTA , pricing policy and reimbursement.
- Planning and implementation of innovative Business Model for a Medical IVF Center, being the first one in Brazilian market structure as a Stock Company.
- Advisory board of one of the first Brazilian Genetic Testing Company focused on non invasive genetic tests to define Nutrigenomic profile.
- Creator and founders of FarmaSustentavel Indicators. A set of business indicators fully oriented to support Pharmaceutical Companies to integrate Sustainability into their business practices. Nowadays applied for more then 30 Pharmaceutical Companies in annually basis.
- Creator of the first Access Medicine Program for Biotech Products, increasing the acess of low purchasing power population to this type of medicine.